Pacific Biosciences of California PACB Business Segments — G&A

Similar metrics at other companies

OUSTReportable Segment — G&A

$16.13M+1.4%

QLYSReportable Segment — G&A

$8.5M-5.3%

DLBReportable Segment — G&A

$64.14M+10.6%

UPWKReportable Segment — G&A

$25.56M+11.4%

PCVXReportable Segment — G&A

$33.07M+1.3%

HNGEReportable Segment — G&A

$19.31M+15.6%

Questions, answered.

What is Pacific Biosciences of California's business segments — G&A?

Pacific Biosciences of California (PACB) reported business segments — G&A of $15.38M in Q1 2026.

How has Pacific Biosciences of California's business segments — G&A changed year-over-year?

Pacific Biosciences of California's business segments — G&A decreased by 23.5% year-over-year, from $20.09M to $15.38M.

What is the long-term trend for Pacific Biosciences of California's business segments — G&A?

Over 3 years (2022 to 2025), Pacific Biosciences of California's business segments — G&A has grown at a -3.6% compound annual growth rate (CAGR), from $76.39M to $68.52M.

What does business segments — G&A mean?

These are the overhead costs associated with the management, legal, human resources, and finance functions required to support the segment's operations. It is a key metric for evaluating the company's operational leverage and the scalability of its corporate infrastructure.